Subthalamic nucleus stimulation induces deficits in decoding emotional facial expressions in Parkinson's disease

Journal of Neurology, Neurosurgery and Psychiatry

Volumn 75, Issue 2, 2004, Pages 202-208

  Dujardin, K ^a,b   Blairy, S ^c   Defebvre, L ^b   Krystkowiak, P ^b   Hess, U ^d   Blond, S ^b   Destee A ^b  

^a LILLE UNIVERSITY HOSPITAL   (France)

^b UNIV LILLE   (France)

^c BRUGMANN UNIVERSITY HOSPITAL   (Belgium)

^d UNIVERSITÉ DU QUÉBEC À MONTRÉAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AFFECT; AGE DETERMINATION; ANXIETY DISORDER; APHASIA; ARTICLE; BASAL GANGLION; CLINICAL ARTICLE; COGNITION; COGNITIVE DEFECT; CONTROLLED STUDY; DEPRESSION; DEPTH PERCEPTION; EDUCATION; ELECTRODE; ELECTROSTIMULATION THERAPY; EMOTIONAL STRESS; FACIAL EXPRESSION; FEMALE; HEMISPHERIC DOMINANCE; HOSPITALIZATION; HUMAN; INFORMATION PROCESSING; INSTRUMENTATION; MALE; NEUROPSYCHOLOGICAL TEST; PARKINSON DISEASE; PATHOPHYSIOLOGY; PERCEPTION DISORDER; PHYSIOLOGY; POSTOPERATIVE PERIOD; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; SEX DIFFERENCE; STIMULATION; SUBTHALAMIC NUCLEUS; TASK PERFORMANCE; VISION;

EID: 0842287598     PISSN: 00223050     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (49)

1. Benazzouz A, Gross C, Feger J, et al. Reversal of rigidity and improvement in motor performance by subthalamic high-frequency stimulation in MPTP-treated monkeys. Eur J Neurosci 1993;5:382-9.
2. Limousin P, Krack P, Pollak P, et al. Electrical stimulation of the subthalamic nucleus in advanced Parkinson's disease. N Engl J Med 1998;339:1105-11.
3. Bergman H, Wichmann T, DeLong MR. Reversal of experimental parkinsonism by lesions of the subthalamic nucleus. Science 1990;249:1436-8.
4. The deep brain stimulation for Parkinson's disease study group. Deep brain stimulation of the subthalamic nucleus of the pars interna of the globus pallidus in Parkinson's disease. N Engl J Med 2001;345:956-63.
5. Benabid AL, Krack PP, Benazzouz A, et al. Deep brain stimulation of the subthalamic nucleus for Parkinson's disease: methodologic aspects and clinical criteria. Neurology 2000;55(suppl 6):S40-4.
6. Romito LM, Scerrati M, Contarino MF, et al. Long-term follow up of subthalamic nucleus stimulation in Parkinson's disease. Neurology 2002;58:1546-50.
7. Diederich NJ, Alesch F, Goetz CG. Visual hallucinations induced by deep brain stimulation in Parkinson's disease. Clin Neuropharmacol 2000;23:287-9.
8. Houeto JL, Damier P, Bejjani PB, et al. Subthalamic stimulation in Parkinson disease: a multidisciplinary approach. Arch Neurol 2000;57:461-5.
9. Houeto JL, Mesnage V, Mallet L, et al. Behavioural disorders, Parkinson's disease and subthalamic stimulation. J Neurol Neurosurg Psychiatry 2002;72:701-7.
10. Fields JA, Troster AI. Cognitive outcomes after deep brain stimulation for Parkinson's disease: A review of initial studies and recommendations for future research. Brain Cogn 2000;42:268-93.
11. Ardouin C, Pillon B, Peiffer E, et al. Bilateral subthalamic or pallidal stimulation for Parkinson's disease affects neither memory nor executive functions: a consecutive series of 62 patients. Ann Neurol 1999;46:217-23.
12. Saint-Cyr JA, Trepanier LL, Kumar R, et al. Neuropsychological consequences of chronic bilateral stimulation of the subthalamic nucleus in Parkinson's disease. Brain 2000;123:2091-108.
13. Trepanier LL, Kumar R, Lozano AM, et al. Neuropsychological Outcome of GPi pallidotomy and GPi or STN deep brain stimulation in Parkinson's disease. Brain Cogn 2000;42:324-47.
14. Bejjani BP, Damier P, Arnulf I, et al. Transient acute depression induced by high-frequency deep-brain stimulation. N Engl J Med 1999;340:1476-80.
15. Dujardin K, Defebvre L, Krystkowiak P, et al. Influence of chronic bilateral stimulation of the subthalamic nucleus on cognitive function in Parkinson's disease. J Neurol 2001;248:603-11.
16. Parent A, Hazrati LN. Functional anatomy of the basal ganglia. I. The cortico-basal ganglia-thalamo-cortical loop. Brain Res Rev 1995;20:91-127.
17. Adolphs R, Tranel D, Damasio H, et al. Impaired recognition of emotion in facial expression following bilateral damage to the human amygdala. Nature 1994;372:669-72.
18. Hornak J, Rolls ET, Wade D. Face and voice expression identification in patients with emotional and behavioural changes following ventral frontal lobe damage. Neuropsychologia 1996;34:247-61.
19. Blair RJ, Morris JS, Frith CD, et al. Dissociable neural responses to facial expressions of sadness and anger. Brain 1999;122:883-93.
20. Whalen PJ, Rauch SL, Etcoff NL, et al. Masked presentations of emotional facial expressions modulate amygdala activity without explicit knowledge. J Neurosci 1998;18:411-18.
21. Morris JS, Ohman A, Dolan RJ. Conscious and unconscious emotional learning in the human amygdala. Nature 1998;393:467-70.
22. Jacobs DH, Shuren J, Heilman KM. Impaired perception of facial identity and facial affect in Huntington's disease. Neurology 1995;45:1217-18.
23. Jacobs DH, Shuren J, Bowers D, et al. Emotional facial imagery, perception and expression in Parkinson's disease. Neurology 1995;45:1696-702.
24. Gibb WRG, Lees A. The relevance of the Lewy Body to the pathogenesis of idiopathic Parkinson's disease. J Neurol Neurosurg Psychiatry 1988;51:745-52.
25. Hoehn, Yahr MD. Parkinsonism: onset, progression and mortality. Neurology 1967;17:427-42.
26. Fahn S, Elton RL, members of the UPDRS development committee. Unified idiopathic Parkinson's disease rating scale. In: Fahn S, Marsden CD, Calne D, eds. Recent developments in Parkinson's disease, vol 2. Florham Park, New Jersey: MacMillan Healthcare Information, 1987:153-64.
27. Hess U, Blairy S. Set of emotional facial stimuli. Montreal: Department of Psychology, University of Quebec at Montreal, 1995.
28. Matsumoto D, Ekman P. Japanese and Caucasian facial expressions of emotion and neutral faces. San Francisco: San Francisco State University, 1988.
29. Philippot P, Kornreich C, Blairy S, et al. Alcoholics' deficits in the decoding of emotional facial expression. Alcohol Clin Exp Res 1999;23:1031-8.
30. Kornreich C, Blairy S, Philippot P, et al. Impaired emotional facial expression recognition in alcoholism compared with obsessive-compulsive disorder and normal controls. Psychiatry Res 2001;102:235-48.
31. Hess U, Blairy S, Kleck R. Intensity of emotional facial expression and decoding accuracy. J Nonverbal Behav 1997;21:241-57.
32. Blairy S, Herrera P, Hess U. Mimicry and the judgment of emotional facial expressions. J Nonverbal Behav 1999;23:5-41.
33. Montgomery SA, Asberg M. A new depression scale designed to be sensitive to change. Br J Psychiatry 1979;134:382-9.
34. Bobon D, von Frenckell R, Troisfontaines B, et al. Construction et validation préliminaire d'une échelle d'anxiété extraite de l'AMDP francophone. L'Encéphale 1985;11:107-11. [In French].
35. Pillon B, Dubois B, Bonnet AM, et al. Cognitive slowing in Parkinson's disease fails to respond to levodopa treatment: The 15-objects test. Neurology 1989;39:762-8.
36. Sprengelmeyer R, Young AW, Mahn K, et al. Facial expression recognition in people with medicated and unmedicated Parkinson's disease. Neuropsychologia 2003;41:1047-57.
37. Doyon J, Bourgeois C, Bedard P. Déficits visuospatiaux associés à la maladie de Parkinson. J Int Psychol 1996;31:161-75. [In French].
38. Finton MJ, Lucas JA, Graff-Radford NR, et al. Analysis of visuospatial errors in patients with Alzheimer's disease or Parkinson's disease. J Clin Exp Neuropsychol 1998;20:186-93.
39. Mandal MK, Tandon SC, Asthana HS. Right brain damage impairs recognition of negative emotions. Cortex 1991;27:247-54.
40. Borod JC. Interhemispheric and intrahemispheric control of emotion: a focus on unilateral brain damage. J Consult Clin Psychol 1992;60:339-48.
41. Benke T, Bösch S, Andree B. A study of emotional processing in Parkinson's disease. Brain Cogn 1998;38:36-52.
42. Joel D, Weiner I. The connections of the dopaminergic system with the striatum in rats and primates: an analysis with respect to the functional and compartmental organization of the striatum. Neuroscience 2000;96:451-74.
43. Karachi C, Yelnik J, Jan C, et al. Cartography of the limbic territory of the subthalamic nucleus of monkeys: a potential target for deep brain stimulation. Mov Disord 2002;17(suppl 5):S18-19.
44. Rodriguez-Oroz MC, Rodriguez M, Guridi J, et al. The subthalamic nucleus in Parkinson's disease: somatotopic organization and physiological characteristics. Brain 2001;124:1777-90.
45. Lanotte MM, Rizzone M, Bergamasco B, et al. Deep brain stimulation of the subthalamic nucleus: anatomical, neurophysiological, and outcome correlations with the effects of stimulation. J Neurol Neurosurg Psychiatry 2002;72:53-8.
46. Vingerhoets FJ, Villemure JG, Temperli P, et al. Subthalamic DBS replaces levodopa in Parkinson's disease: two-year follow-up. Neurology 2002;58:396-401.
47. Lawrence AD, Calder AJ, McGowan SW, et al. Selective disruption of the recognition of facial expressions of anger. Neuroreport 2002;13:881-4.
48. Welter ML, Houeto JL, Tezenas Du Montcel S, et al. Clinical predictive factors of subthalamic stimulation in Parkinson's disease. Brain 2002;125:575-83.
49. Patterson ML. The evolution of a parallel process model of nonverbal communication. In: Philippot P, Feldman RS, Coats EJ, eds. The social context of nonverbal behavior. New York: Cambridge University Press, 1999.